PT  - JOURNAL ARTICLE
AU  - Luke N Allen
AU  - Simon Wigley
AU  - Hampus Holmer
TI  - Study protocol: Assessing the association between corporate political influence and implementation of policies to tackle commercial determinants of non-communicable diseases: a cross-sectional analysis of 172 countries
AID  - 10.1101/2021.07.15.21260066
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.15.21260066
4099  - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260066.short
4100  - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260066.full
AB  - Objectives To assess the association between corporate political influence and implementation of WHO-recommended policies to constrain sales, marketing and consumption of tobacco, alcohol, and unhealthy foods.Design Cross-sectional analysis using national datasets from 2015, 2017, and 2020.Setting Global analysis of data from 172 of the 194 WHO Member StatesMain outcome measures We will use random effects multivariate regression to test the association between implementation status of 12 WHO-recommended tobacco, alcohol, and diet policies and corporate political influence, a metric that combines disclosure of campaign donations, public campaign finance, corporate campaign donations, legislature corrupt activities, disclosure by politicians, and executive oversight. We will control for GDP per capita, population aged >65 years, urbanization, level of democracy, continent, ethno-linguistic fractionalization, legal origin, Small Island Developing States, and Muslim population (to capture alcohol policy differences). We will include year dummies to address the possibility of a spurious relationship between the outcome variable and the independent variables of interests. For example, there may be an upward global trend in policy implementation that coincides with an upward global trend in in the regulation of lobbying and campaign finance.Ethics and dissemination As this study uses publicly available data, ethics approval is not required. The authors have no conflicts of interest to declare. Findings will be submitted to a peer-reviewed journal for publication in the academic literature. All data, code, and syntax will be made publicly available on GitHub.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for the development of this protocolAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, code, and syntax will be made publicly available on GitHub. https://github.com/drlukeallen/CDOH-policy-implementation